Acinetobacter baumannii is a Gram-negative, opportunistic bacterium that causes hospital-acquired infections in Microbiology. It is notorious for multidrug resistance and survival on surfaces.
Acinetobacter baumannii is a Gram-negative, opportunistic pathogen in Microbiology, meaning it usually causes the worst problems in people who are already sick, injured, or medically vulnerable. You will most often see it discussed as a healthcare-associated bacterium, especially in pneumonia, bloodstream infections, and wound infections.
What makes A. baumannii stand out is not just that it infects people, but that it can hang around in hospital environments and resist many of the drugs used against it. It can survive on dry surfaces for long periods, so bed rails, equipment, and other shared surfaces can become part of the transmission story. That persistence is one reason it is such a problem in intensive care units and other settings where patients are exposed to lots of devices and frequent contact.
In a microbiology course, this organism shows up as a good example of how structure, ecology, and genetics come together. As a Gram-negative bacterium, it has the outer membrane typical of that group, and that membrane is part of the challenge for antibiotic treatment. On top of that, it can acquire resistance genes through horizontal gene transfer, which lets it pick up new defenses from other microbes rather than waiting only for slow random mutation.
A big term connected to this organism is carbapenem resistance. Carbapenems are broad-spectrum beta-lactam antibiotics, so when A. baumannii becomes resistant to them, treatment options narrow fast. That is why the phrase CRAB, short for carbapenem-resistant A. baumannii, comes up so often in clinical microbiology. CRAB is a classic example of how drug resistance turns a familiar infection into a difficult hospital problem.
If you are tracing this organism in class, think in this order: exposure in a healthcare setting, colonization or infection in a vulnerable patient, acquisition or expression of resistance mechanisms, and then a tougher treatment decision. That cause-and-effect chain is the real story behind the name.
Acinetobacter baumannii matters because it ties together several big Microbiology ideas at once: Gram-negative cell structure, opportunistic infection, antibiotic resistance, and hospital transmission. If you can explain this organism, you can usually explain why certain infections are hard to treat in clinical settings.
It also gives you a clear example of how resistance changes the entire clinical picture. A bacterium that might already be difficult to eliminate becomes much more serious when it can resist carbapenems or other common drugs. That is where drug resistance stops being an abstract topic and becomes a real treatment problem.
This term also shows up in comparisons with other resistant bacteria. When your class talks about hospital pathogens, A. baumannii often appears alongside other resistant Gram-negative organisms because it raises the same questions: How did the infection spread? What antibiotics are left? What resistance mechanism is involved?
If you are reading a case study, this is the organism that pushes you to think beyond just naming the microbe. You have to connect the patient setting, the likely route of spread, and the resistance pattern to make sense of the diagnosis and treatment options.
Keep studying MICROBIO Unit 14
Visual cheatsheet
view galleryHorizontal Gene Transfer
A. baumannii is a strong example of how bacteria pick up useful genes from other microbes. Horizontal gene transfer can move resistance genes into a strain that was once easier to treat, which helps explain why hospital outbreaks can become harder over time. When you see this term with A. baumannii, think gene sharing, not just slow mutation.
Carbapenems
Carbapenems are often reserved for serious bacterial infections, so resistance to them is a big warning sign. In A. baumannii, carbapenem resistance can leave very few treatment options and often points to a more clinically urgent case. This connection is why the organism is frequently discussed in drug resistance units.
Colistin
Colistin is one of the last-resort drugs sometimes used against highly resistant Gram-negative bacteria, including some A. baumannii infections. Its mention usually means the case has already moved past many standard antibiotic choices. If colistin appears in a question, the focus is often on why treatment is so limited and risky.
Antibiotic Stewardship
Antibiotic stewardship is the practice of using antibiotics carefully so resistance does not spread as quickly. A. baumannii shows why that matters, since heavy antibiotic use in hospitals can select for strains that survive and multiply. This connection is about prevention at the population level, not just treating one infection.
A quiz item or case study may give you a hospital patient with pneumonia, a wound infection, or a bloodstream infection and ask you to identify A. baumannii as the likely resistant pathogen. You might also be asked to explain why it is so hard to treat, using clues like Gram-negative structure, carbapenem resistance, or surface survival. In a lab or image question, you could be shown a Gram stain result, a resistance profile, or a hospital outbreak scenario and need to connect the organism to healthcare-associated infection. When the prompt mentions CRAB, the move is to recognize that it means carbapenem-resistant A. baumannii and then explain why that changes treatment choices.
Both A. baumannii and CRE are associated with hard-to-treat hospital infections, so they get mixed up easily. The difference is that A. baumannii is a specific species, while CRE is a broader group of Enterobacteriaceae that resist carbapenems. If the question gives a named organism versus a bacterial family category, that is the clue.
Acinetobacter baumannii is a Gram-negative opportunistic pathogen that shows up most often in healthcare-associated infections.
It is known for surviving on environmental surfaces and spreading in hospital settings, especially where patients are already vulnerable.
Its ability to acquire resistance genes makes it a major example of multidrug resistance in Microbiology.
Carbapenem-resistant A. baumannii, or CRAB, is especially concerning because it leaves fewer effective antibiotic choices.
When you see this term, connect the organism to hospital infection, antibiotic resistance, and difficult treatment decisions.
Acinetobacter baumannii is a Gram-negative bacterium that commonly causes opportunistic, hospital-acquired infections. In Microbiology, it is usually discussed as a multidrug-resistant pathogen that can cause pneumonia, bloodstream infections, and wound infections.
It is hard to treat because many strains carry antibiotic resistance genes and can resist multiple drug classes, including carbapenems. That resistance narrows treatment options and can force doctors to consider combination therapy or last-resort drugs.
It can survive on dry environmental surfaces for a long time, which makes contaminated equipment and shared surfaces a problem. Spread is more likely in healthcare settings where patients have wounds, catheters, ventilators, or weak immune systems.
No. A. baumannii is one specific bacterial species, while CRE refers to carbapenem-resistant Enterobacteriaceae, which is a larger group of bacteria. They are both resistance problems, but they are not the same organism or the same bacterial family.